EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India
EUDA (NASDAQ: EUDA) announced on October 23, 2025 that its wholly owned subsidiary CK Health Plus will expand into India via a master license and representative partnership with SafeRock India.
The agreement aims to deploy CK Health Plus’ Bioenergy Capsule Therapies and EUDA Helixé supplements across major Indian cities including Mumbai and Bangalore, leveraging SafeRock India’s systems integration capabilities and nationwide network to roll out a network-marketing wellness ecosystem.
EUDA (NASDAQ: EUDA) ha annunciato il 23 ottobre 2025 che la sua controllata al 100% CK Health Plus si espanderà in India tramite una licenza maestra e una partnership di rappresentanza con SafeRock India.
L'accordo prevede di distribuire le Bioenergy Capsule Therapies di CK Health Plus e gli integratori EUDA Helixé nelle principali città indiane tra cui Mumbai e Bangalore, sfruttando le capacità di integrazione di sistemi di SafeRock India e la rete a livello nazionale per sviluppare un ecosistema di benessere basato sul marketing di rete.
EUDA (NASDAQ: EUDA) anunció el 23 de octubre de 2025 que su subsidiaria de propiedad total CK Health Plus se expandirá a la India mediante una licencia maestra y una asociación de representantes con SafeRock India.
El acuerdo tiene como objetivo desplegar las Bioenergy Capsule Therapies de CK Health Plus y los suplementos EUDA Helixé en las principales ciudades de la India, incluyendo Mumbai y Bangalore, aprovechando las capacidades de integración de sistemas de SafeRock India y su red nacional para desplegar un ecosistema de bienestar de mercadeo en red.
EUDA(NASDAQ: EUDA)는 2025년 10월 23일 자회사인 CK Health Plus가 SafeRock India와의 마스터 라이선스 및 대리점 파트너십을 통해 인도로 확장할 것이라고 발표했습니다.
계약은 CK Health Plus의 Bioenergy Capsule Therapies와 EUDA Helixé 보충제를 뭄바이 및 벵갈루루를 포함한 인도의 주요 도시들에 배치하는 것을 목표로 하며, SafeRock India의 시스템 통합 역량과 전국 네트워크를 활용해 네트워크 마케팅 방식의 웰니스 생태계를 구축합니다.
EUDA (NASDAQ: EUDA) a annoncé le 23 octobre 2025 que sa filiale en propriété exclusive CK Health Plus s’étendra en Inde via une licence maîtresse et un partenariat de représentation avec SafeRock India.
L’accord vise à déployer les Bioenergy Capsule Therapies de CK Health Plus et les compléments EUDA Helixé dans les principales villes indiennes, y compris Mumbai et Bangalore, en tirant parti des capacités d’intégration de SafeRock India et de son réseau national pour déployer un écosystème de bien-être axé sur le marketing de réseau.
EUDA (NASDAQ: EUDA) gab am 23. Oktober 2025 bekannt, dass ihre vollständig im Eigentum befindliche Tochtergesellschaft CK Health Plus in Indien durch eine Masterlizenz und eine Vertreterpartnerschaft mit SafeRock India expandieren wird.
Der Vertrag zielt darauf ab, die Bioenergy Capsule Therapies von CK Health Plus und die EUDA Helixé-Ergänzungen in den wichtigsten indischen Städten, einschließlich Mumbai und Bangalore, bereitzustellen und dabei SafeRock Indias Systemintegrationsfähigkeiten sowie das landesweite Netzwerk zu nutzen, um ein MLM-Wellness-Ökosystem auszurollen.
أعلنت شركة EUDA (بورصة ناسداك: EUDA) في 23 أكتوبر 2025 أن شركتها الفرعية المملوكة بالكامل CK Health Plus ستتوسع إلى الهند عبر ترخيص رئيسي وشراكة تمثيل مع SafeRock India.
تهدف الاتفاقية إلى نشر Bioenergy Capsule Therapies من CK Health Plus ومكملات EUDA Helixé في المدن الهندية الرئيسية بما في ذلك مومباي وبنغالور، مع الاستفادة من قدرات تكامل الأنظمة لدى SafeRock India وشبكتها الوطنية لدفع نظام صحي يعتمد على التسويق الشبكي.
- None.
- None.
Insights
CK Health Plus announces a master‑license partnership to enter India, offering distribution and network‑marketing for wellness products.
The move pairs CK Health Plus and SafeRock India to deploy Bioenergy Capsule Therapies and EUDA Helixé supplements across major Indian cities, leveraging SafeRock India’s systems integration and nationwide network to accelerate market access after
Execution depends on local regulatory approvals, supply‑chain setup, and consumer acceptance of network‑marketing channels; these practical steps materially affect commercial uptake and timing. Regulatory clearances and distribution roll‑out present the main near‑term risks.
Watch for evidence of: formal product registrations, announced pilot city launches, local pricing and margin disclosures, and reported user adoption metrics over the next 6–18 months. These milestones will clarify revenue potential and operational scale.
SINGAPORE, Oct. 23, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-owned subsidiary, CK Health Plus Sdn. Bhd. (“CK Health Plus”), will expand into the Indian market through a strategic master license and representative partnership with SafeRock India Private Limited (“SafeRock India”), a SafeRock India Private Limited leading systems integration and infrastructure solutions companies in India.
Market Opportunity and Growth Potential
India is emerging as one of the most dynamic frontiers in the global wellness and preventive healthcare industry. The nation’s rapidly growing middle class, accelerating urbanization, and increasing focus on long-term health have created ideal conditions for a new wave of wellness innovation. A shift is underway as consumers increasingly seek healthier lifestyles, longevity, and self-care with trusted, science-based solutions that align with modern living.
Partnering for Rapid Strategic Market Entry
This partnership marks CK Health Plus’ entry into one of the world’s largest and fastest-growing wellness and direct selling markets. SafeRock India, a Bangalore-based company with deep roots in technology integration and a nationwide network, will spearhead CK Health Plus’ expansion across major cities including Mumbai, Bangalore, and Karnataka, with future plans to extend into additional key regions.
Building a Sustainable Wellness Ecosystem
The partnership combines CK Health Plus’ cutting-edge Bioenergy Capsule Therapies and EUDA Helixé supplements with SafeRock India’s strong operational presence and extensive local network. Together, both companies aim to build a sustainable wellness ecosystem that empowers individuals with preventive health solutions and entrepreneurial opportunities through CK Health Plus’ network marketing platform.
Executive Commentary
Mr. Alex Lai, CEO of CK Health Plus, commented:
“Our partnership with SafeRock India represents the next frontier in our regional expansion. SafeRock India’s proven infrastructure and trusted market presence give CK Health Plus the reach and foundation needed to deliver scientifically-backed wellness solutions across India. This partnership embodies our mission to bring preventive healthcare and longevity solutions to every community through innovation, accessibility, and trust.”
About EUDA Health Holdings Limited
EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based leading non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China. The Company aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over 1.8 billion people across the region which is experiencing significant demographic shifts as more than
Forward-Looking Statements
This document may contain forward-looking statements regarding risks and uncertainties. These statements usually use forward-looking words, such as the words “estimates,” “projected,” “expects,” “envisions,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions). These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside EUDA’s and CK Health Plus’ control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. You should not overly rely on forward-looking statements that are only applicable to the date of publication of this document. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.